Viking Therapeutics, Up 62% Since August, Lingers In Buy Zone On An Obesity Win

investors.com/news/technology/viking-therapeutics-stock-enrollment-phase-3-vk2735

Viking Therapeutics stock yo-yoed Wednesday after the company said it overenrolled one of its final-phase studies for its weight-loss shot.
The post Viking Therapeutics, Up 62% Since August, Lingers In Buy Zone On An Obesity Win appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-11-19 15:51:20.
The Entire Business World on a Single Page. Free to Use →